表紙
市場調查報告書
商品編碼
1028766

PCR 市場:qPCR、dPCR、Singleplex、Multiplex 市場:應用、產品、位置:執行和顧問指南(包括定制預測和分析):Covid-19 診斷影響最新報告(2021 年)~2025 年)

PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to include impact of Covid-19 Dx. 2021 to 2025

出版日期: | 出版商: Howe Sound Research | 英文 384 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

COVID-19 的診斷使 PCR 成為一項專有技術,刺激了基於 PCR 的新技術的發展。 PCR 已經在市場上證明了它的存在。新一代 PCR 數字 PCR 有望延續這一成功。在對大流行診斷的巨大需求的推動下,它將進一步加速。新的靈敏度水平也將影響液體活檢和癌症篩查市場。

本報告調查了 PCR 市場,並按應用、產品、位置和進入市場的公司概況提供了市場概況、趨勢。

目錄

第 1 章市場指南

  • 情況分析
  • 高管和營銷人員指南
  • 投資分析師和管理顧問指南

第 2 章市場的介紹和定義

  • 什麼是 PCR 技術?
  • PCR 和症候群檢測
  • 市場定義
    • 市場規模
    • 貨幣
  • 調查方法
    • 作者
    • 來源
  • 前景:醫療保健、IVD 行業和 COVID-19 大流行
    • 全球醫療保健支出
    • 診斷費用
    • 保險對診斷的重要作用

第 3 章 PCR-PCR 技術指南

  • 概念
    • 方法
  • 使用
    • 特定DNA的發現
    • DNA 測量
    • 醫療和診斷應用
  • PCR-優點和缺點
  • 各種類型的 PCR
    • 簡單的改變
    • 數位 PCR
    • 等溫 PCR

第 4 章行業概況

  • 充滿活力的市場參與者
    • 學術研究室
    • 診斷測試開發人員
    • 基因組儀器供應商
    • 醫藥/試劑供應商
    • 獨立實驗室
    • 公共國家/地區研究所
    • 醫院實驗室
    • 從業者實驗室
    • 審計機構
    • 認證機構

第 5 章市場趨勢

  • 生長促進因素
    • 新標準
    • 向下曲線
    • 多路復用
    • 證候診斷不能停
    • 遺傳性暴風雪症候群
  • 生長抑制因素
    • 成本曲線
    • 其他人
    • 系統性殘疾
  • 診斷技術的發展
    • 儀表曲線
    • 診斷角色的變化
    • 診斷在院外
    • 混亂正在逼近
    • 未來 5 年

第 6 章 PCR 的最新發展

第 7 章主要 PCR 公司簡介

  • Abacus Diagnostica
  • Abbott Diagnostics
  • Accelerate Diagnostics
  • Ador Diagnostics
  • Agilent
  • Akonni Biosystems
  • Alveo Technologies
  • Applied BioCode
  • Aus Diagnostics
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Binx Health
  • Biocartis
  • bioM?rieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Caris Molecular Diagnostics
  • Cepheid(now Danaher)
  • Credo Diagnostics Biomedical
  • Cue Health
  • Curetis N.V./Curetis GmbH
  • Diagenode Diagnostics
  • Diasorin S.p.A
  • Enzo Life Sciences, Inc
  • Eurofins Scientific
  • Fluidigm Corp
  • Fluxergy
  • Fusion Genomics
  • Genetic Signatures
  • GenMark Dx
  • Hibergene Diagnostics
  • Hologic
  • Immunexpress
  • Inflammatix
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexagene
  • LightDeck Diagnostics
  • Luminex Corp
  • Maxim Biomedical
  • Mbio Diagnostics
  • Meridian Bioscience
  • Mesa Biotech
  • Millipore Sigma
  • MIODx
  • Mobidiag
  • Nanomix
  • NGeneBio
  • Operon
  • Panagene
  • Perkin Elmer
  • Precipio
  • Primerdesign
  • Promega
  • Prominex
  • Qiagen Gmbh
  • Quantumdx
  • Quidel
  • Roche Molecular Diagnostics
  • Saw Diagnostics
  • Seegene
  • Siemens Healthineers
  • SkylineDx
  • Sona Nanotech
  • SpeeDx
  • T2 Biosystems
  • Thermo Fisher Scientific Inc
  • Veramarx
  • Visby Medical
  • XCR Diagnostics

第 8 章全球 PCR 市場

  • PCR-按國家/地區分列的全球市場概覽
    • Table-World Markets by Country
    • 按國家/地區繪製世界市場
  • 按應用劃分的全球市場-概覽
    • Table-World 市場按應用
    • 圖表世界市場-按應用-細分市場增長
    • 圖表世界市場-按應用程序基礎/最終比較
    • 圖表-世界市場-按使用基年
    • 圖表-世界市場-按用途-最後一年
    • 圖表-世界市場-按使用-份額按年
  • 世界市場-按技術-概覽
    • Table-World Market-By Technology
    • 圖表-世界市場-按技術-細分市場增長
    • 圖表世界市場-按技術基礎/最終比較
    • 圖表-世界市場-按技術-基礎年
    • 圖表-世界市場-按技術-最後一年
    • 圖表-世界市場-按技術-年份額
  • 按產品分類的全球市場概覽
    • Table-World Market-By Product
    • 圖表世界市場-按產品細分市場增長
    • 圖表世界市場-按產品基礎/最終比較
    • 圖表-世界市場-按產品-基準年
    • 圖表-世界市場-按產品-最後一年
    • 圖表-世界市場-按產品-年份額
  • 世界市場-按位置-概覽
    • Table-World Markets-By Location
    • 圖表-世界市場-按位置-細分市場增長
    • 圖表-世界市場-按位置基礎/最終比較
    • 圖表-世界市場-按位置-基準年
    • 圖表-世界市場-按位置-最後一年
    • 圖表-世界市場-按位置-按年份額

第 9 章全球 PCR 市場-按應用

  • PCR臨床多重
  • PCR 臨床單鏈
  • PCR 調查
  • PCR 單 C19
  • 其他

第 10 章全球 PCR 市場-按技術

  • qPCR
  • dPCR
  • 單 C19 PCR
  • 其他

第 11 章全球 PCR 市場-副產品

  • PCR 裝置
  • PCR核酸提取
  • PCR耗材
  • PCR 服務

第 12 章全球 PCR 市場-按位置

  • 臨床實驗室
  • 護理點
  • 商業
  • 製藥
  • 其他

第 13 章附錄

目錄

OVERVIEW:

COVID-19 Diagnostics is driving PCR into a dominant technology role and spurring the growth of new PCR based technologies. Will thermal cycling become obsolete?

Are singleplex tests going to be obsolete? Will routine respiratory screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

The report forecasts the market size out to 2025 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Driven even faster by the huge demand for pandemic diagnostics. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

  • 2.1 What are PCR Technologies?
  • 2.2 PCR and Syndromic Testing
  • 2.3 Market Definition
    • 2.3.1 Market Size
    • 2.3.2 Currency
    • 2.3.3 Years
  • 2.4 Methodology
    • 2.4.1 Authors
    • 2.4.2 Sources
  • 2.5 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic
    • 2.5.1 Global Healthcare Spending
    • 2.5.2 Spending on Diagnostics
    • 2.5.3 Important Role of Insurance for Diagnostics

3 PCR - Guide to PCR Technologies

  • 3.1 Concepts
    • 3.1.1 Method
  • 3.2 Applications
    • 3.2.1 Finding Specific DNA
    • 3.2.2 Measuring DNA
    • 3.2.3 Medical and Diagnostic Applications
      • 3.2.3.1 Carrier, prenatal and tissue typing
      • 3.2.3.2 Cancer Diagnosis and Management
      • 3.2.3.3 Infectious Disease - New Levels of Accuracy and Sensitivity
      • 3.2.3.4 Forensic Applications
      • 3.2.3.5 Science and Research
  • 3.3 PCR - Advantages and Disadvantages
  • 3.4 Different Types of PCR
    • 3.4.1 Simple Changes
      • 3.4.1.1 Multiplex-PCR
      • 3.4.1.2 VNTR PCR
      • 3.4.1.3 Asymmetric PCR
      • 3.4.1.4 Long PCR
      • 3.4.1.5 Nested PCR
      • 3.4.1.6 Quantitative PCR
      • 3.4.1.7 Hot-start PCR
      • 3.4.1.8 Touchdown PCR
      • 3.4.1.9 Assembly PCR
      • 3.4.1.10 Colony PCR
      • 3.4.1.11 Suicide PCR
      • 3.4.1.12 Cold PCR
    • 3.4.2 Digital PCR
      • 3.4.2.1 Droplet Digital PCR
      • 3.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)
      • 3.4.2.3 Digital PCR in Use
      • 3.4.2.4 Digital PCR Commercial History
    • 3.4.3 Isothermal PCR

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Diagnostic Test Developer
    • 4.1.3 Genomic Instrumentation Supplier
      • 4.1.3.1 Cell Separation and Viewing Instrumentation Supplier
    • 4.1.4 Pharmaceutical/Reagent Supplier
    • 4.1.5 Independent Testing Lab
    • 4.1.6 Public National/regional lab
    • 4.1.7 Hospital lab
    • 4.1.8 Physician Lab
    • 4.1.9 Audit Body
    • 4.1.10 Certification Body

5 Market Trends

  • 5.1 Factors Driving Growth
    • 5.1.1 A New Standard
    • 5.1.2 Down the Curve We Go
    • 5.1.3 Multiplexing
    • 5.1.4 Syndromic Diagnostics Looks Unstoppable
    • 5.1.5 The Genetic Blizzard
  • 5.2 Factors Limiting Growth
    • 5.2.1 The Cost Curve
    • 5.2.2 The Other Guys
    • 5.2.3 Systemic Roadblocks
  • 5.3 Diagnostic Technology Development
    • 5.3.1 The Instrumentation Curve
    • 5.3.2 Shifting Role of Diagnostics
    • 5.3.3 Diagnostics Moves Out of the Hospital
    • 5.3.4 Disruption Looms
    • 5.3.5 The Next Five Years

6 PCR Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 Chelex-Based Protocol to Reduce Cost, Time for PCR Testing
  • 6.3 Finnish Firms to Form Point-of-Care Testing Firm
  • 6.4 Visby Medical Scales Up Handheld PCR Test for STIs
  • 6.5 DnaNudge Raises $60M
  • 6.6 Roche Reports Diagnostics Revenue Up 51 Percent
  • 6.7 BforCure Preparing Multiple ID Panels for PoC qPCR Platform
  • 6.8 Enzo Biochem, CLX Health Partner for C19 Testing for Travel
  • 6.9 Bio Molecular Systems Gets Approval for Portable PCR Cycler
  • 6.10 Roche Acquires GenMark
  • 6.11 Handheld qPCR Devices Close to Commercialization
  • 6.12 Nuclein Closes $14M in Funding
  • 6.13 WuXi Diagnostics Closes $150M Series B Financing Round
  • 6.14 Visby Medical to develop rapid Flu-COVID PCR test
  • 6.15 Thermo Fisher to acquire Mesa Biotech
  • 6.16 Scope Fluidics Secures €6.2M Supporting Rapid MDx
  • 6.17 SARS- Testing Demand to Continue 'Through 2022, and Beyond'
  • 6.18 Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
  • 6.19 Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
  • 6.20 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
  • 6.21 HelixBind Receives $3M NIH Grant to Expand Infection Dx Platform
  • 6.22 Nucleix Targeting US Market With Bladder, Lung Cancer Assays
  • 6.23 DxTerity Gets CE Mark for At-Home Sample Collection Device
  • 6.24 Fetal Cell-Based NIPT by dDigital PCR Demonstrated
  • 6.25 ChromaCode Raises $28M for new High Def PCR Technology
  • 6.26 ddPCR Used for Fast and Low-Cost NIPT Screening
  • 6.27 Study Validates ChromaCode HDPCR™ Testing for Tick-Borne Pathogens
  • 6.28 Bio-Rad's ddPCR MSI RUO Assay is available
  • 6.29 ctDNA Monitoring Is Important for BRAF-Mutant Melanoma
  • 6.30 Sysmex Inostics Liquid Biopsy Demonstrates Two-fold Higher Detection
  • 6.31 QIAGEN Plans for Next-Generation Digital PCR Systems
  • 6.32 Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
  • 6.33 New PCR Technology: Transfer-PCR (tPCR) Applications
  • 6.34 NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
  • 6.35 Natera Applies Massively Multiplexed PCR to Kidney Transplants
  • 6.36 Paragon Genomics, MGI Tech Form Distribution Alliance

7 Profiles of Key PCR Companies

  • 7.1 Abacus Diagnostica
  • 7.2 Abbott Diagnostics
  • 7.3 Accelerate Diagnostics
  • 7.4 Ador Diagnostics
  • 7.5 Agilent
  • 7.6 Akonni Biosystems
  • 7.7 Alveo Technologies
  • 7.8 Applied BioCode
  • 7.9 Aus Diagnostics
  • 7.10 Beckman Coulter Diagnostics
  • 7.11 Becton, Dickinson and Company
  • 7.12 Binx Health
  • 7.13 Biocartis
  • 7.14 bioMérieux Diagnostics
  • 7.15 Bioneer Corporation
  • 7.16 Bio-Rad Laboratories, Inc
  • 7.17 Bosch Healthcare Solutions GmbH
  • 7.18 Bruker
  • 7.19 Caris Molecular Diagnostics
  • 7.20 Cepheid (now Danaher)
  • 7.21 Credo Diagnostics Biomedical
  • 7.22 Cue Health
  • 7.23 Curetis N.V. / Curetis GmbH
  • 7.24 Diagenode Diagnostics
  • 7.25 Diasorin S.p.A
  • 7.26 Enzo Life Sciences, Inc
  • 7.27 Eurofins Scientific
  • 7.28 Fluidigm Corp
  • 7.29 Fluxergy
  • 7.30 Fusion Genomics
  • 7.31 Genetic Signatures
  • 7.32 GenMark Dx
  • 7.33 Hibergene Diagnostics
  • 7.34 Hologic
  • 7.35 Immunexpress
  • 7.36 Inflammatix
  • 7.37 Invetech
  • 7.38 Janssen Diagnostics
  • 7.39 Karius
  • 7.40 Lexagene
  • 7.41 LightDeck Diagnostics
  • 7.42 Luminex Corp
  • 7.43 Maxim Biomedical
  • 7.44 Mbio Diagnostics
  • 7.45 Meridian Bioscience
  • 7.46 Mesa Biotech
  • 7.47 Millipore Sigma
  • 7.48 MIODx
  • 7.49 Mobidiag
  • 7.50 Nanomix
  • 7.51 NGeneBio
  • 7.52 Operon
  • 7.53 Panagene
  • 7.54 Perkin Elmer
  • 7.55 Precipio
  • 7.56 Primerdesign
  • 7.57 Promega
  • 7.58 Prominex
  • 7.59 Qiagen Gmbh
  • 7.60 Quantumdx
  • 7.61 Quidel
  • 7.62 Roche Molecular Diagnostics
  • 7.63 Saw Diagnostics
  • 7.64 Seegene
  • 7.65 Siemens Healthineers
  • 7.66 SkylineDx
  • 7.67 Sona Nanotech
  • 7.68 SpeeDx
  • 7.69 T2 Biosystems
  • 7.70 Thermo Fisher Scientific Inc
  • 7.71 Veramarx
  • 7.72 Visby Medical
  • 7.73 XCR Diagnostics

8 The Global PCR Markets

  • 8.1 PCR - Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Market by Application - Overview
    • 8.2.1 Table - Global Market by Application
    • 8.2.2 Chart - Global Market by Application - Segments Growth
    • 8.2.3 Chart - Global Market by Application - Base/Final Comparison
    • 8.2.4 Chart - Global Market by Application - Base Year
    • 8.2.5 Chart - Global Market by Application - Final Year
    • 8.2.6 Chart - Global Market by Application - Share by Year
  • 8.3 Global Market by Technology - Overview
    • 8.3.1 Table - Global Market by Technology
    • 8.3.2 Chart - Global Market by Technology - Segments Growth
    • 8.3.3 Chart - Global Market by Technology - Base/Final Comparison
    • 8.3.4 Chart - Global Market by Technology - Base Year
    • 8.3.5 Chart - Global Market by Technology - Final Year
    • 8.3.6 Chart - Global Market by Technology - Share by Year
  • 8.4 Global Market by Product - Overview
    • 8.4.1 Table - Global Market by Product
    • 8.4.2 Chart - Global Market by Product - Segments Growth
    • 8.4.3 Chart - Global Market by Product - Base/Final Comparison
    • 8.4.4 Chart - Global Market by Product - Base Year
    • 8.4.5 Chart - Global Market by Product - Final Year
    • 8.4.6 Chart - Global Market by Product - Share by Year
  • 8.5 Global Market by Place - Overview
    • 8.5.1 Table - Global Market by Place
    • 8.5.2 Chart - Global Market by Place - Segments Growth
    • 8.5.3 Chart - Global Market by Place - Base/Final Comparison
    • 8.5.4 Chart - Global Market by Place - Base Year
    • 8.5.5 Chart - Global Market by Place - Final Year
    • 8.5.6 Chart - Global Market by Place - Share by Year

9 Global PCR Markets - By Application

  • 9.1 PCR Clinical Multiplex
    • 9.1.1 Table PCR Clinical Multiplex Testing - by Country
    • 9.1.2 Chart - PCR Clinical Multiplex Testing Growth
  • 9.2 PCR Clinical Singleplex
    • 9.2.1 Table PCR Clinical Singleplex Testing - by Country
    • 9.2.2 Chart - PCR Clinical Singleplex Testing Growth
  • 9.3 PCR Research
    • 9.3.1 Table PCR Research - by Country
    • 9.3.2 Chart - PCR Research Growth
  • 9.4 PCR Single C19
    • 9.4.1 Table PCR Single C19 - by Country
    • 9.4.2 Chart - PCR Single C19 Growth
  • 9.5 PCR Other
    • 9.5.1 Table PCR Other - by Country
    • 9.5.2 Chart - PCR Other Growth

10 Global PCR Markets - By Technology

  • 10.1 qPCR
    • 10.1.1 Table qPCR - by Country
    • 10.1.2 Chart - qPCR Growth
  • 10.2 dPCR
    • 10.2.1 Table dPCR - by Country
    • 10.2.2 Chart - dPCR Growth
  • 10.3 Single C19 PCR
    • 10.3.1 Table Single C19 PCR - by Country
    • 10.3.2 Chart - Single C19 PCR Growth
  • 10.4 Other PCR
    • 10.4.1 Table Other PCR - by Country
    • 10.4.2 Chart - Other PCR Growth

11 Global PCR Markets - By Product

  • 11.1 PCR Instruments
    • 11.1.1 Table PCR Instruments - by Country
    • 11.1.2 Chart - PCR Instruments Growth
  • 11.2 PCR Nucleic Acid Extraction
    • 11.2.1 Table PCR Nucleic Acid Extraction - by Country
    • 11.2.2 Chart - PCR Nucleic Acid Extraction Growth
  • 11.3 PCR Consumables
    • 11.3.1 Table PCR Consumables - by Country
    • 11.3.2 Chart - PCR Consumables Growth
  • 11.4 PCR Services
    • 11.4.1 Table Services - by Country
    • 11.4.2 Chart - PCR Services Growth

12 Global PCR Markets - By Place

  • 12.1 PCR Clinical Laboratory
    • 12.1.1 Table PCR Clinical Clinical Laboratory - by Country
    • 12.1.2 Chart - PCR Clinical Clinical Laboratory Growth
  • 12.2 PCR Point of Care
    • 12.2.1 Table PCR Point of Care - by Country
    • 12.2.2 Chart - PCR Point of Care Growth
  • 12.3 PCR Commercial
    • 12.3.1 Table PCR Commercial - by Country
    • 12.3.2 Chart - PCR Commercial Growth
  • 12.4 PCR Pharmaceutical
    • 12.4.1 Table PCR Pharmaceutical - by Country
    • 12.4.2 Chart - PCR Pharmaceutical Growth
  • 12.5 PCR Other Place
    • 12.5.1 Table PCR Other Place - by Country
    • 12.5.2 Chart - PCR Other Place Growth

13 Appendices

  • 13.1 I. United States Medicare System: 2021 Clinical Laboratory Fees Schedule

Table of Tables

  • Table 1 Market Players by Type
  • Table 2 Five Factors Driving Growth
  • Table 3 Three Factors Limiting Growth
  • Table 4 Market Size by Country
  • Table 5 Global Market by Application
  • Table 6 Global Market by Technology
  • Table 7 Global Market by Product
  • Table 8 Global Market by Place
  • Table 9 PCR Clinical Multiplex by Country
  • Table 10 PCR Clinical Singleplex by Country
  • Table 11 PCR Research by Country
  • Table 12 PCR Single C19 by Country
  • Table 13 PCR Other by Country
  • Table 14 qPCR by Country
  • Table 15 Single C19 PCR by Country
  • Table 16 Other PCR by Country
  • Table 17 PCR Instruments by Country
  • Table 18 PCR Nucleic Acid Extraction by Country
  • Table 19 PCR Consumables by Country
  • Table 20 PCR Services by Country
  • Table 21 PCR Clinical Clinical Laboratory by Country
  • Table 22 PCR Point of Care by Country
  • Table 23 PCR Commercial by Country
  • Table 24 PCR Pharmaceutical by Country
  • Table 25 PCR Other Place by Country
  • Table 26 2021 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Map - Global Health Care Spending Per Capita
  • Figure 2 The Lab Test Pie - Wholesale vs. Retail
  • Figure 3 The PCR Process
  • Figure 4 Creation of Sample Droplets for Digital PCR
  • Figure 5 Comparing Syndromic and Targeted Testing
  • Figure 6 Comparing The New Diagnostics and Traditional Testing
  • Figure 7 Growth rates of PCR Diagnostic Segments
  • Figure 8 Base year Global Market Share Chart
  • Figure 9 PCR Market by Application - Segments Growth
  • Figure 10 PCR Market by Application - Base vs. final
  • Figure 11 PCR Market Base year
  • Figure 12 PCR Market Final Year
  • Figure 13 Application Share by Year
  • Figure 14 PCR Market by Technology - Segments Growth
  • Figure 15 PCR Market by Technology - Base vs. final
  • Figure 16 PCR Market by Technology Base year
  • Figure 17 PCR Market by Technology Final Year
  • Figure 18 Technology Share by Year
  • Figure 19 PCR Market by Product - Segments Growth
  • Figure 20 PCR Market by Product - Base vs. final
  • Figure 21 PCR Market by Product Base year
  • Figure 22 PCR Market by Product Final Year
  • Figure 23 Product Share by Year
  • Figure 24 PCR Market by Place - Segments Growth
  • Figure 25 PCR Market by Place - Base vs. final
  • Figure 26 PCR Market by Place Base year
  • Figure 27 PCR Market by Place Final Year
  • Figure 28 Place Share by Year
  • Figure 29 PCR Clinical Multiplex Testing Growth
  • Figure 30 PCR Clinical Singleplex Testing Growth
  • Figure 31 PCR Research Growth
  • Figure 32 PCR Single C19 Growth
  • Figure 33 PCR Other Growth
  • Figure 34 qPCR Growth
  • Figure 35 dPCR Growth
  • Figure 36 Single C19 PCR Growth
  • Figure 37 Other PCR Growth
  • Figure 38 PCR Instruments Growth
  • Figure 39 PCR Nucleic Acid Extraction Growth
  • Figure 40 PCR Consumables Growth
  • Figure 41 PCR Services Growth
  • Figure 42 PCR Clinical Clinical Laboratory Growth
  • Figure 43 PCR Point of Care Growth
  • Figure 44 PCR Commercial Growth
  • Figure 45 PCR Pharmaceutical Growth
  • Figure 46 PCR Other Place Growth